Epigral Faces Volatility Amidst Mixed Performance Against Broader Market Trends

Epigral, a midcap player in the chemicals industry, experienced a notable decline of 5.08% on March 10, 2025, underperforming its sector by 4.93%. The stock opened the day with a gain of 3.37%, reaching an intraday high of Rs 1926.95, but quickly reversed course, hitting a low of Rs 1766.6, reflecting high volatility with an intraday fluctuation of 5.94%.
Despite today's downturn, Epigral has shown resilience over the past week, boasting a 13.78% increase compared to the Sensex's modest 1.41% rise. However, its performance over the past month indicates a decline of 5.73%, slightly worse than the Sensex's 4.13% drop. Over the last three months, Epigral's stock has decreased by 17.39%, while the Sensex fell by 9.07%.

In the longer term, Epigral has demonstrated significant growth, with a 55.90% increase over the past year, contrasting sharply with the Sensex's near-zero change. Year-to-date, the stock is down 6.87%, compared to the Sensex's decline of 5.15%. Overall, Epigral's performance metrics reflect a complex landscape amid broader market trends.